SIRT2-IN-9
SIRT2-IN-9 (compound 12) is a selective inhibitor of SRIT2 with an IC50 value of 1.3 μM. SIRT2-IN-9 inhibits proliferative activity of MCF-7 breast cancer cells. SIRT2-IN-9 can be used for the research of cancer[1].
Product Specifications
CAS Number
[522650-91-5]
UNSPSC
12352005
Hazard Statement
H315-H319
Target
Sirtuin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sirt2-in-9.html
Purity
99.45
Solubility
DMSO : 4.46 mg/mL (ultrasonic; warming; heat to 70°C)
Smiles
O=C(NC1=NC(CCCC2)=C2S1)CSC3=NN=C4C(N(CCC)C5=C4C=CC=C5)=N3
Molecular Formula
C21H22N6OS2
Molecular Weight
438.57
Precautions
P264-P280-P302+P352-P305+P351+P338-P362+P364
References & Citations
[1]Yang SY, Li LL. The purposes of 5H- [1,2,4] triazine [5,6-b] indole derivatives of 3 substitutions. CN108309982A. 2017.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SIRT1; SIRT2; SIRT3
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
OR2B11 (NM_001004492) Human Tagged ORF Clone Lentiviral Particle
Recombinant Paracoccus denitrificans GTP cyclohydrolase folE2 (folE2)
Recombinant Paracoccus denitrificans GTP cyclohydrolase folE2 (folE2)
Recombinant Paracoccus denitrificans GTP cyclohydrolase folE2 (folE2)
Recombinant Paracoccus denitrificans GTP cyclohydrolase folE2 (folE2)
